The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose
Konstantelos N, Kim S, Cheung AM, Burden AM, Grootendorst P, Cadarette SM. Osteoporos Int. 2025 Sep 4 [Epub ahead of print].
Konstantelos N, Kim S, Cheung AM, Burden AM, Grootendorst P, Cadarette SM. Osteoporos Int. 2025 Sep 4 [Epub ahead of print].
Shogry FF, Hayes KN, Kim S, Burden AM, Tadrous M, Aggarwal S, Cadarette SM. Osteoporos Int. 2025; Jun 11 [Epub ahead of prin]t.
Hayes KN, Sendhil S, Aggarwal S, Zullo AR, Berry SD, Oganisian A, Adegboye M, Cadarette SM. JBMR Plus. 2025;9(6): ziaf061. Epub 2025 Apr 11.
Hayes KN, Zullo AR, Berry SD, Oganisian A, Aggarwal S, Adegboye M, Cadarette SM. Osteoporos Int. 2025; Apr 2. [Epub ahead of print].
Rzepka AM, Cheung AM, Kim S, Gomes T, Cadarette SM. JBMR Plus. 2024; 8(5):ziae027. Epub 2024 April 9, 2024.
Konstantelos N, Burden AM, Cheung AM, Kim S, Grootendorst P, Cadarette SM. Pharmacy. 2023; 11(2):53. Epub 2023 Mar 14.
Rzepka AM, Wong L, Chaudhry M, Sproule BA, He N, Cadarette SM. Can Pharm J (Ott). 2022; 155(4):194-9. Epub 2022 Jun 20.
Hayes KN, Brown KA, Cheung AM, Kim SA, Juurlink DN, Cadarette SM. Ann Intern Med. 2022; 175(3):335-43. Epub 2022 Jan 11.
Chaudhry M, He N, Waite NM, Houle SKD, Kwong JC, Cadarette SM. Can Pharm J (Ott). 2021; 154(5):305-11. Epub 2021 Aug 11.
Cadarette SM, He N, Chaudhry M, Dolovich L. Can Pharm J (Ott). 2021; 154(3):153-9. Epub 2021 May 28.